212 related articles for article (PubMed ID: 34634688)
1. High concentration of hydrogen gas alleviates Lipopolysaccharide-induced lung injury via activating Nrf2 signaling pathway in mice.
Sun R; Zhao N; Wang Y; Su Y; Zhang J; Wang Y; Yu Y; Wang G; Wang Z; Xie K
Int Immunopharmacol; 2021 Dec; 101(Pt B):108198. PubMed ID: 34634688
[TBL] [Abstract][Full Text] [Related]
2. Molecular hydrogen ameliorates lipopolysaccharide-induced acute lung injury in mice through reducing inflammation and apoptosis.
Xie K; Yu Y; Huang Y; Zheng L; Li J; Chen H; Han H; Hou L; Gong G; Wang G
Shock; 2012 May; 37(5):548-55. PubMed ID: 22508291
[TBL] [Abstract][Full Text] [Related]
3. Downregulated microRNA-27b attenuates lipopolysaccharide-induced acute lung injury via activation of NF-E2-related factor 2 and inhibition of nuclear factor κB signaling pathway.
Huang Y; Huang L; Zhu G; Pei Z; Zhang W
J Cell Physiol; 2019 May; 234(5):6023-6032. PubMed ID: 30584668
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of pogostone against LPS-induced acute lung injury in mice via regulation of Keap1-Nrf2/NF-κB signaling pathways.
Sun CY; Xu LQ; Zhang ZB; Chen CH; Huang YZ; Su ZQ; Guo HZ; Chen XY; Zhang X; Liu YH; Chen JN; Lai XP; Li YC; Su ZR
Int Immunopharmacol; 2016 Mar; 32():55-61. PubMed ID: 26800098
[TBL] [Abstract][Full Text] [Related]
5. Songorine inhibits oxidative stress-related inflammation through PI3K/AKT/NRF2 signaling pathway to alleviate lipopolysaccharide-induced septic acute lung injury.
Fang J; Huang Q; Shi C; Gai L; Wang X; Yan B
Immunopharmacol Immunotoxicol; 2024 Apr; 46(2):152-160. PubMed ID: 37977206
[TBL] [Abstract][Full Text] [Related]
6. Azilsartan attenuates lipopolysaccharide-induced acute lung injury via the Nrf2/HO-1 signaling pathway.
Zhang C; Zhao Y; Yang X
Immunol Res; 2022 Feb; 70(1):97-105. PubMed ID: 34608599
[TBL] [Abstract][Full Text] [Related]
7. hucMSC Conditioned Medium Ameliorate Lipopolysaccharide-Induced Acute Lung Injury by Suppressing Oxidative Stress and Inflammation via Nrf2/NF-
Tang Y; Ding F; Wu C; Liu B
Anal Cell Pathol (Amst); 2021; 2021():6653681. PubMed ID: 34426780
[TBL] [Abstract][Full Text] [Related]
8. Physalin B ameliorates inflammatory responses in lipopolysaccharide-induced acute lung injury mice by inhibiting NF-κB and NLRP3 via the activation of the PI3K/Akt pathway.
Zhong R; Xia T; Wang Y; Ding Z; Li W; Chen Y; Peng M; Li C; Zhang H; Shu Z
J Ethnopharmacol; 2022 Feb; 284():114777. PubMed ID: 34737012
[TBL] [Abstract][Full Text] [Related]
9. Hydrogen Gas Inhalation Attenuates Seawater Instillation-Induced Acute Lung Injury via the Nrf2 Pathway in Rabbits.
Diao M; Zhang S; Wu L; Huan L; Huang F; Cui Y; Lin Z
Inflammation; 2016 Dec; 39(6):2029-2039. PubMed ID: 27596008
[TBL] [Abstract][Full Text] [Related]
10. Dexmedetomidine attenuates lipopolysaccharide induced acute lung injury in rats by inhibition of caveolin-1 downstream signaling.
Liu J; Huang X; Hu S; He H; Meng Z
Biomed Pharmacother; 2019 Oct; 118():109314. PubMed ID: 31545263
[TBL] [Abstract][Full Text] [Related]
11. Bardoxolone treatment alleviates lipopolysaccharide (LPS)-induced acute lung injury through suppressing inflammation and oxidative stress regulated by Nrf2 signaling.
Pei X; Zhang XJ; Chen HM
Biochem Biophys Res Commun; 2019 Aug; 516(1):270-277. PubMed ID: 31248593
[TBL] [Abstract][Full Text] [Related]
12. β-Patchoulene from patchouli oil protects against LPS-induced acute lung injury via suppressing NF-κB and activating Nrf2 pathways.
Chen XY; Dou YX; Luo DD; Zhang ZB; Li CL; Zeng HF; Su ZR; Xie JH; Lai XP; Li YC
Int Immunopharmacol; 2017 Sep; 50():270-278. PubMed ID: 28711783
[TBL] [Abstract][Full Text] [Related]
13. Xanthohumol ameliorates lipopolysaccharide (LPS)-induced acute lung injury via induction of AMPK/GSK3β-Nrf2 signal axis.
Lv H; Liu Q; Wen Z; Feng H; Deng X; Ci X
Redox Biol; 2017 Aug; 12():311-324. PubMed ID: 28285192
[TBL] [Abstract][Full Text] [Related]
14. Obacunone alleviates ferroptosis during lipopolysaccharide-induced acute lung injury by upregulating Nrf2-dependent antioxidant responses.
Li J; Deng SH; Li J; Li L; Zhang F; Zou Y; Wu DM; Xu Y
Cell Mol Biol Lett; 2022 Mar; 27(1):29. PubMed ID: 35305560
[TBL] [Abstract][Full Text] [Related]
15. Isovitexin Exerts Anti-Inflammatory and Anti-Oxidant Activities on Lipopolysaccharide-Induced Acute Lung Injury by Inhibiting MAPK and NF-κB and Activating HO-1/Nrf2 Pathways.
Lv H; Yu Z; Zheng Y; Wang L; Qin X; Cheng G; Ci X
Int J Biol Sci; 2016; 12(1):72-86. PubMed ID: 26722219
[TBL] [Abstract][Full Text] [Related]
16. Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-κB signaling pathway and MMP-9 expression.
Zhang X; Sun CY; Zhang YB; Guo HZ; Feng XX; Peng SZ; Yuan J; Zheng RB; Chen WP; Su ZR; Huang XD
J Ethnopharmacol; 2016 Jun; 186():91-102. PubMed ID: 27036629
[TBL] [Abstract][Full Text] [Related]
17. Gastrodin protects against LPS-induced acute lung injury by activating Nrf2 signaling pathway.
Zhang Z; Zhou J; Song D; Sun Y; Liao C; Jiang X
Oncotarget; 2017 May; 8(19):32147-32156. PubMed ID: 28389632
[TBL] [Abstract][Full Text] [Related]
18. Ethyl ferulate protects against lipopolysaccharide-induced acute lung injury by activating AMPK/Nrf2 signaling pathway.
Wu YX; Wang YY; Gao ZQ; Chen D; Liu G; Wan BB; Jiang FJ; Wei MX; Zuo J; Zhu J; Chen YQ; Qian F; Pang QF
Acta Pharmacol Sin; 2021 Dec; 42(12):2069-2081. PubMed ID: 34417573
[TBL] [Abstract][Full Text] [Related]
19. Ulinastatin Protects Against LPS-Induced Acute Lung Injury By Attenuating TLR4/NF-κB Pathway Activation and Reducing Inflammatory Mediators.
Cao C; Yin C; Shou S; Wang J; Yu L; Li X; Chai Y
Shock; 2018 Nov; 50(5):595-605. PubMed ID: 29324628
[TBL] [Abstract][Full Text] [Related]
20. Cordycepin alleviates lipopolysaccharide-induced acute lung injury via Nrf2/HO-1 pathway.
Qing R; Huang Z; Tang Y; Xiang Q; Yang F
Int Immunopharmacol; 2018 Jul; 60():18-25. PubMed ID: 29702279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
